Stevanato Group

About Stevanato Group

Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The company offers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle, from development to commercial stages, with a focus on managing complexity and delivering value.

Products & Services

Drug Containment Solutions:Over 75 years of experience in producing glass primary packaging for the pharmaceutical industry, including vial systems, cartridge systems, syringe systems, ampoules, and platforms like EZ-fill and Nexa.

Drug Delivery Systems:Unique solutions based on contract manufacturing, integrated capabilities, and technologies, including auto-injectors (Aidaptus), pen injectors (Alina), and on-body delivery systems (Vertiva).

In-Vitro Diagnostics & Medical Solutions:Development and manufacturing of point-of-care devices, in-vitro diagnostic consumables, and medical solutions tailored to customer needs.

Technologies & Equipment:Includes glass converting lines for pharmaceutical containers, device assembly and packaging equipment, visual inspection systems, tooling for precision mechanics, after-sales services, and digitalization solutions.

Analytical & Testing Services:Services to investigate physico-chemical properties of container closure systems and drug interactions, including chemical analysis, surface characterization, and container performance testing.

Specialties

Drug Containment Solutions Drug Delivery Systems In-Vitro Diagnostics Glass Primary Packaging Visual Inspection Systems Analytical Testing Services Biologics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt Financing T: - FT: Debt Financing	A: 200000000 MR: - FA: €200 million FAN: 200000000	D: 2025-07-23 FD: 2025-07-23	3 investors
2	RT: Public Offering T: - FT: Public Offering	A: 379700000 MR: - FA: 379.7 million FAN: 379700000	D: 2024-03-26 FD: 2024-03-26	5 investors
3	RT: Public Offering T: - FT: Public Offering	A: 330000000 MR: - FA: approximately $330 million FAN: 330000000	D: 2024-03-21 FD: 2024-03-21	5 investors
4	RT: Debt T: - FT: Debt	A: 130000000 MR: - FA: €130 million FAN: 130000000	D: 2023-03-08 FD: 2023-03-08	2 investors

Debt Financing Latest

2025-07-23

$200.0M

3 investors (Pro only)

Public Offering 2024-03-26

$379.7M

Public Offering 2024-03-21

$330.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Stevanato Group Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised